share_log

Singapore's Manufacturing Output Grows by 8.5% in November 2024

Singapore's Manufacturing Output Grows by 8.5% in November 2024

新加坡的製造業產出在2024年11月增長了8.5%。
Singapore Business Review ·  01/05 21:11

In electronics, output increased 26.2% YoY.

在電子產品中,產量同比增長26.2%。

Singapore's manufacturing output increased by 8.5% in November 2024 on a year-on-year (YoY) basis.

新加坡的製造業產量在2024年11月同比增長了8.5%。

Excluding biomedical manufacturing, output increased by 13%. On a seasonally adjusted month-on-month basis, manufacturing output decreased by 0.4% during the period.

不包括生物醫藥製造,產量增長了13%。在季節性調整的環比基礎上,製造業產量在此期間下降了0.4%。

In electronics, output increased by 26.2% YoY with the semiconductors, computer peripherals and data storage, and infocomms and consumer electronics segments growing by 28.8%, 23.6%, and 8.7% respectively.

在電子產品中,產量同比增長26.2%,其中半導體、計算機外設和數據存儲、信息通信及消費電子板塊分別增長了28.8%、23.6%和8.7%。

As for precision engineering, output increased by 0.6% YoY with the machinery and systems segment increasing by 4.3%, led by higher production of front-end semiconductor equipment.

至於精密工程,產量同比增長了0.6%,機械和系統板塊增長了4.3%,主要得益於前端半導體設備的生產增加。

The chemicals markets saw a decline of 1.1% due to other chemicals decreasing by 5% with a lower output of fragrances and the specialties segment contracting by 28%. This offset the petroleum and petrochemicals segments, which grew by 11.3% and 1.1% respectively.

化學品市場下降了1.1%,由於其他化學品下降了5%,香料的產量減少,特種板塊收縮了28%。這抵消了石油股和石油與天然氣板塊的增長,後者分別增長了11.3%和1.1%。

Additionally, transport engineering dipped by 1.8%. Whilst the aerospace segment grew by 20.9%, the land, marine and offshore engineering segments decreased by 12.8% and 24.9%, respectively.

此外,交通工程下降了1.8%。雖然航空航天板塊增長了20.9%,但陸地、海洋和離岸工程板塊分別下降了12.8%和24.9%。

Furthermore, general manufacturing output decreased by 2.6% with all segments, including printing and food, and beverages and tobacco, recording output declines.

此外,綜合製造業產量下降了2.6%,所有板塊,包括印刷、食品、飲料和煙草,均記錄了產量下降。

Lastly, biomedical manufacturing contracted by 21.2%. The medical technology segment grew by 5.8%, however, the pharmaceuticals segment declined by 37.1%.

最後,生物醫藥製造收縮了21.2%。醫療科技部門增長了5.8%,然而,製藥部門下降了37.1%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論